Baldwin Investment Management, LLC Bristol Myers Squibb CO Transaction History

Baldwin Investment Management, LLC

$721 Million
Q2 2024

A detailed history of Baldwin Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 11,849 shares of BMY stock, worth $643,637. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,849

Previous 17,479 32.21%

Holding current value

$643,637

Previous $947,000 48.05%

% of portfolio

0.07%

Previous 0.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $226,607 - $298,333	-5,630 Reduced 32.21%	11,849 $492,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $31,186 - $35,360	-650 Reduced 3.59%	17,479 $947,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $736,168 - $878,452	-15,185 Reduced 45.58%	18,129 $930,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1.22 Million - $1.36 Million	-21,021 Reduced 38.69%	33,314 $1.93 Million
Q2 2023 Aug 01, 2023	SELL	$63.71 - $70.74 $451,194 - $500,980	-7,082 Reduced 11.53%	54,335 $3.47 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $129,514 - $146,898	-1,971 Reduced 3.11%	61,417 $4.26 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $77,040 - $91,226	-1,125 Reduced 1.74%	63,388 $4.56 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $689 - $407,328	-5,301 Reduced 7.59%	64,513 $4.59 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $204,933 - $225,703	-2,822 Reduced 3.89%	69,814 $5.38 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $100,827 - $120,900	1,640 Added 2.31%	72,636 $5.31 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $260,963 - $304,222	-4,866 Reduced 6.41%	70,996 $4.43 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $46,803 - $54,824	791 Added 1.05%	75,862 $4.49 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $176,319 - $192,012	2,848 Added 3.94%	75,071 $5.02 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $277,473 - $312,076	4,676 Added 6.92%	72,223 $4.56 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $632,945 - $717,243	10,962 Added 19.37%	67,547 $4.19 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $987,738 - $1.09 Million	17,199 Added 43.67%	56,585 $3.41 Million
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $41,992 - $49,092	766 Added 1.98%	39,386 $2.32 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $277,240 - $402,894	5,975 Added 18.3%	38,620 $2.15 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.07 Million - $1.39 Million	21,720 Added 198.81%	32,645 $2.1 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $29,554 - $35,040	691 Added 6.75%	10,925 $554,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $456,641 - $504,945	10,234 New	10,234 $464,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $185,398 - $221,064	-4,109 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $22,076 - $24,900	-400 Reduced 8.87%	4,109 $255,000
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $227,839 - $283,976	4,509 New	4,509 $250,000

Others Institutions Holding BMY

# of Institutions

2,444

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.

Account

Baldwin Investment Management, LLC Bristol Myers Squibb CO Transaction History